Aligos Therapeutics
ALGS
ALGS
38 hedge funds and large institutions have $25.3M invested in Aligos Therapeutics in 2022 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 9 increasing their positions, 13 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
31% less repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 13
93% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 15
Holders
38
Holding in Top 10
2
Calls
$7K
Puts
–
Top Buyers
| 1 | +$1.09M | |
| 2 | +$476K | |
| 3 | +$37.4K | |
| 4 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$31.4K |
| 5 |
NYLIM
New York Life Investment Management
New York
|
+$28.3K |
Top Sellers
| 1 | -$2.15M | |
| 2 | -$200K | |
| 3 | -$189K | |
| 4 |
Rockefeller Capital Management
New York
|
-$85K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$72.9K |